About
Adam Simpson joined Frazier Life Sciences as a Venture Partner in 2024, focusing on company creation. He co-founded and served as CEO of Icosavax (Nasdaq: ICVX), leading it through IPO and acquisition by AstraZeneca, and previously was CEO of PvP Biologics (acquired by Takeda) and co-founder/Chief Business Officer of Meritage Pharma (sold to Shire). He began his career as a life sciences transactions attorney at Latham & Watkins and holds a B.S. in biochemistry from UC San Diego and a J.D. from the University of Minnesota Law School.
Invests in
Biotech
Experience
- Frazier Life SciencesVenture Partnercurrent2024 — present
- Callio TherapeuticsExecutive Board Chaircurrent2024 — present
- Icosavax, Inc.Chief Executive Officer, Board Member & Co-Founder2017 — 2024
- PvP Biologics, Inc.Chief Executive Officer & Board Member2016 — 2020
- Cypher GenomicsPresident & Chief Operating Officer2013 — 2016
- Meritage Pharma, Inc.Chief Business Officer & Co-Founder2008 — 2012
- Verus PharmaceuticalsGeneral Counsel2005 — 2008
- Latham & WatkinsAssociate1999 — 2005
Skills & more
StrategyVenture Capital1CommercializationBiotechnologyGenomicsMergers & AcquisitionsStart-upsLicensingFDAPharmaceutical IndustryVaccines
From Adam's professional profile.
Investments
Board seats
Callio Therapeutics
Per the firm's website.
Colleagues at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
April Petersen
Senior Accountant at Frazier Life Sciences
Frequently asked questions
- Who is Adam Simpson?
- Adam Simpson joined Frazier Life Sciences as a Venture Partner in 2024, focusing on company creation. He co-founded and served as CEO of Icosavax (Nasdaq: ICVX), leading it through IPO and acquisition by AstraZeneca, and previously was CEO of PvP Biologics (acquired by Takeda) and co-founder/Chief Business Officer of Meritage Pharma (sold to Shire). He began his career as a life sciences transactions attorney at Latham & Watkins and holds a B.S. in biochemistry from UC San Diego and a J.D. from the University of Minnesota Law School.
- Where does Adam Simpson work?
- Adam Simpson is Venture Partner at Frazier Life Sciences.
- What does Adam Simpson invest in?
- Adam Simpson invests in Biotech.
- What boards does Adam Simpson sit on?
- Adam Simpson holds tracked board seats at Callio Therapeutics.
- Where did Adam Simpson go to school?
- Adam Simpson studied at UC San Diego (B.S., Biochemistry); University of Minnesota Law School (J.D.).
Same school
Also attended UC San Diego329
Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi
+ 323 more
Also attended University of Minnesota Law School8
Liz FowlerExecutive Advisor at LRVHealthKatherine M. BryanInvestor at Madison Dearborn PartnersYrjö OjasaarInvestment Partner at Change VenturesDanny BriskinOperating Partner, Human Resources at Greybull Stewardship LLCTom ThomasGeneral Counsel at Alpha Intelligence CapitalBenInvestor at OPAMP CAPITAL
+ 2 more
Shared employers
Also worked at Latham & Watkins66
Chen Yang SiaGeneral Counsel at Golden Gate VenturesSapna MehtaInvestor at RevolutionThea CrawshawInvestor at Index VenturesJuliette PetitChief of Staff at Keen Venture PartnersChen YangAdvisor at Golden Gate VenturesChristopher WestSenior Legal Counsel at Qualcomm Ventures
+ 60 more